company logo

Vice President, Clinical Research at Intercept Pharmaceuticals in San Diego, CA



$250K — $500K+*


Allied Health Professionals, Life Sciences, Healthcare Management


11 - 15 years

Job Description

See More

Valid through: 8/13/2020

About Intercept Pharmaceuticals

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC), non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea. The companys lead product is Obeticholic acid, OCA, also known as 6-ethyl-chenodeoxycholic acid or INT-747. OCA is a potent first-in-class farnesoid X receptor (FXR) agonist. It is currently in phase III studies for primary biliary cirrhosis, and phase II studies for other diseases including NASH. Other products in the development pipeline include INT-767, a dual FXR/TGR5 agonist, and INT-777, a TGR5 agonist.
Total Jobs:
Total Experts:
Average Pay:
Total value of jobs:
% Masters:
Learn More About Intercept Pharmaceuticals
* Ladders Estimates

More Jobs at Intercept Pharmaceuticals

Similar Jobs

More Pharmaceuticals & Biotech Jobs

Director of Production - Cannabis

$110K — $140K

Confidential Company

Niagara Falls, ON L2E 0A1


Find similar Vice President of Life Sciences jobs: